Danske Bank A S Makes New Investment in Agilent Technologies, Inc. $A

Danske Bank A S bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 245,094 shares of the medical research company’s stock, valued at approximately $32,556,000. Danske Bank A S owned 0.09% of Agilent Technologies at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Diversify Advisory Services LLC bought a new stake in shares of Agilent Technologies in the second quarter valued at approximately $446,000. Wealthfront Advisers LLC increased its stake in Agilent Technologies by 13.2% during the 2nd quarter. Wealthfront Advisers LLC now owns 22,930 shares of the medical research company’s stock worth $3,046,000 after acquiring an additional 2,682 shares during the period. Meeder Advisory Services Inc. raised its holdings in Agilent Technologies by 15.1% in the 2nd quarter. Meeder Advisory Services Inc. now owns 8,850 shares of the medical research company’s stock valued at $1,176,000 after acquiring an additional 1,159 shares in the last quarter. Meeder Asset Management Inc. raised its holdings in Agilent Technologies by 13,407.7% in the 2nd quarter. Meeder Asset Management Inc. now owns 27,961 shares of the medical research company’s stock valued at $3,714,000 after acquiring an additional 27,754 shares in the last quarter. Finally, Citizens Financial Group Inc. RI lifted its position in shares of Agilent Technologies by 41.0% during the 2nd quarter. Citizens Financial Group Inc. RI now owns 6,047 shares of the medical research company’s stock valued at $803,000 after acquiring an additional 1,759 shares during the period.

Wall Street Analyst Weigh In

Several research firms have commented on A. Piper Sandler assumed coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price on the stock. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target for the company. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their price objective for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. Finally, Morgan Stanley upped their target price on Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Stock Up 4.7%

A stock opened at $155.40 on Thursday. The firm has a 50-day moving average price of $136.44 and a 200-day moving average price of $125.84. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $43.89 billion, a P/E ratio of 31.20, a price-to-earnings-growth ratio of 2.63 and a beta of 1.25.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm’s revenue was up 10.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.